These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24809972)

  • 1. Pulmonary haemorrhage from therapeutic rivaroxaban use: chest radiograph consolidation is not always infection!
    Wong A; Koutsogiannis Z; Greene SL
    Emerg Med Australas; 2014 Jun; 26(3):318-9. PubMed ID: 24809972
    [No Abstract]   [Full Text] [Related]  

  • 2. Life-threatening haemorrhagic pericarditis associated with rivaroxaban.
    Xu B; MacIsaac A
    Int J Cardiol; 2014 Jun; 174(2):e75-6. PubMed ID: 24794963
    [No Abstract]   [Full Text] [Related]  

  • 3. Gaining experience with the NOACs.
    Kamphuisen PW
    Blood; 2014 Aug; 124(6):836. PubMed ID: 25104864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericardial bleeding risk with non-vitamin K oral anticoagulants: a meta-analysis.
    Caldeira D; Barra M; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
    Int J Cardiol; 2015 Mar; 182():187-8. PubMed ID: 25577761
    [No Abstract]   [Full Text] [Related]  

  • 5. Rıvaroxaban-induced severe diffuse ıntracerebral hemorrhage.
    Çalışkan F; Akdemir HU; Nurata H; Akdemir N; Başara G; Yavuz Y
    Am J Emerg Med; 2015 Mar; 33(3):475.e1-5. PubMed ID: 25218622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe drug-induced skin and liver injury from rivaroxaban.
    Barrett P; Vuppalanchi R; Masuoka H; Chalasani N
    Dig Dis Sci; 2015 Jun; 60(6):1856-8. PubMed ID: 25559757
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivaroxaban 2.5 mg. No justification for using this anticoagulant after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):229-32. PubMed ID: 25964962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous rectus sheath hematoma during rivaroxaban therapy.
    Kocayigit I; Can Y; Sahinkus S; Aydın E; Vatan MB; Kılıc H; Gunduz H
    Indian J Pharmacol; 2014; 46(3):339-40. PubMed ID: 24987185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oral anticoagulants (NOAC) and liver injury.
    Moore N; Blin P; Gulmez SE
    J Hepatol; 2014 Aug; 61(2):198-9. PubMed ID: 24837361
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.
    Piccini JP; Garg J; Patel MR; Lokhnygina Y; Goodman SG; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Nessel CC; Mahaffey KW; Singer DE; Califf RM; Fox KA;
    Eur Heart J; 2014 Jul; 35(28):1873-80. PubMed ID: 24658769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CONKO-011: Evaluation of patient satisfaction with the treatment of acute venous thromboembolism with rivaroxaban or low molecular weight heparin in cancer patients. A randomized phase III study].
    Riess H; Sinn M; Kreher S;
    Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S22-3. PubMed ID: 26069043
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
    Reddy P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and laboratory testing of the oral Xa inhibitors.
    Samama MM; Meddahi S; Samama CM
    Clin Lab Med; 2014 Sep; 34(3):503-17. PubMed ID: 25168939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban in acute coronary syndromes--is it prime time?
    Asrar ul Haq M; van Gaal WJ
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):649-58. PubMed ID: 24746010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Tamponade Associated with Rivaroxaban.
    Boone S
    Del Med J; 2015 Jul; 87(7):206-7. PubMed ID: 26285318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated hemopericardium associated with rivaroxaban: first case report.
    Shivamurthy P; Brar N; Therrien ML
    Pharmacotherapy; 2014 Sep; 34(9):e169-72. PubMed ID: 25074401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
    Sherid M; Sifuentes H; Sulaiman S; Samo S; Husein H; Tupper R; Thiruvaiyaru D; Spurr C; Sridhar S
    Digestion; 2014; 90(2):137-46. PubMed ID: 25278002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rivaroxaban - Largest Study Program with novel oral anticoagulants].
    van Eickels M
    Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S27. PubMed ID: 26069045
    [No Abstract]   [Full Text] [Related]  

  • 19. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
    Cappato R; Ezekowitz MD; Klein AL; Camm AJ; Ma CS; Le Heuzey JY; Talajic M; Scanavacca M; Vardas PE; Kirchhof P; Hemmrich M; Lanius V; Meng IL; Wildgoose P; van Eickels M; Hohnloser SH;
    Eur Heart J; 2014 Dec; 35(47):3346-55. PubMed ID: 25182247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban postmarketing risk of liver injury.
    Russmann S; Niedrig DF; Budmiger M; Schmidt C; Stieger B; Hürlimann S; Kullak-Ublick GA
    J Hepatol; 2014 Aug; 61(2):293-300. PubMed ID: 24681117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.